APA (7th ed.) Citation

Maria Mazzitelli, Milo Gatti, Vincenzo Scaglione, Daniele Mengato, Marco Trevenzoli, Andrea Sattin, . . . Anna Maria Cattelan. (2022). Off-Label Use of Dalbavancin for Sequential Treatment of Spondylodiscitis by Methicillin-Resistant <i>Staphylococcus aureus</i>: A Retrospective Single-Centre Experience. MDPI AG.

Chicago Style (17th ed.) Citation

Maria Mazzitelli, Milo Gatti, Vincenzo Scaglione, Daniele Mengato, Marco Trevenzoli, Andrea Sattin, Federico Pea, and Anna Maria Cattelan. Off-Label Use of Dalbavancin for Sequential Treatment of Spondylodiscitis by Methicillin-Resistant <i>Staphylococcus Aureus</i>: A Retrospective Single-Centre Experience. MDPI AG, 2022.

MLA (9th ed.) Citation

Maria Mazzitelli, et al. Off-Label Use of Dalbavancin for Sequential Treatment of Spondylodiscitis by Methicillin-Resistant <i>Staphylococcus Aureus</i>: A Retrospective Single-Centre Experience. MDPI AG, 2022.